Life Sciences

GSK collaborates with Chinese giant Zhifei on a $3 bill...

GSK has established a strategic partnership with Chongqing Zhifei Biological Pro...

Zeiss and Boehringer Ingelheim have formed an AI-backed...

A recently established collaboration between Zeiss Medical Technology and Boehri...

Novartis Receives Great Reviews For Iptacon Phase 3 Per...

In the context of clinical trials, Novartis has achieved a significant milestone...

FDA Imposes Partial Clinical Hold on Innate Pharma’s Ly...

Innate Pharma, a prominent player in the biotechnology sector, has encountered a...

Fractyl’s GLP-1 Obesity Gene Therapy Performs Well in W...

During a presentation at the annual meeting of the European Association for the ...

FDA grants authorization to Invitae DNA test to identif...

The healthcare sector is undergoing rapid changes, with genetic testing leading ...

Takeda Wagers $580M on AcuraStem’s ALS Treatments

As scientific investigations in the current year persist in highlighting the PIK...

Gilead Abruptly Halts Phase 3 Leukemia Trial Following ...

Another failure has befallen the immuno-oncology wager that Gilead Sciences plac...

Roche pays Ionis $60 million for RNA-targeting Alzheime...

After facing obstacles in its Alzheimer’s trials for gantenerumab the previous y...

FDA approves RYZUMVI for pharmacologically-induced mydr...

Viatris Inc. and Ocuphire Pharma, Inc. have received the go-ahead from the U.S. ...

Overcoming Age-Related Challenges in Nanodrug Delivery ...

The efficacy of medical treatments often varies with age, and this principle hol...

60 Degrees Pharmaceuticals Halts Tafenoquine COVID-19 T...

In accordance with FDA guidance, 60 Degrees Pharmaceuticals has opted to halt th...

Phase 3 trial data for Astellas’s GA drug yielded posit...

A mere six weeks after obtaining FDA approval, Astellas Pharma is already consid...

Morphic’s EMERALD-1 trial for ulcerative colitis disapp...

Investors have raised a concern about Morphic’s eagerly awaited EMERALD-1 trial....

Ionis sees success in lipid reduction Phase 3 trial

Ionis Pharmaceuticals has achieved a significant milestone in their phase 3 clin...

Sanofi divests 11 CNS medications to Pharmanovia in a s...

In a strategic maneuver aimed at streamlining its product portfolio, pharmaceuti...